We confirm all patient/personal identifiers have

been removed or disguised so the patient/person(s) described are not identifiable and cannot be identified through the details of the story. The authors declare that there is no conflict of interest. JM had the idea for the study, led the data analyses and wrote the first draft of the report. AS undertook the BIBF 1120 mw interviews and participated in analysis of the resulting data. AQ assisted in conceptual work and data presentation. KN was the Principal Investigator for the CAMWEL trial and is the guarantor for this study. All authors participated in discussions about the design of this study, contributed to revisions of the report and approved the submission of the final report. The CAMWEL trial was funded by the Camden Primary Care Trust FDA-approved Drug Library (NHS Camden). JM is supported by a Wellcome Trust Research Career Development Fellowship in Basic Biomedical Science (WT086516MA). The sponsor and funder had no role in the decision to publish nor in the writing of this paper. “
“The devastating diagnosis of incurable cancer has a major effect on patients’ well-being [1],

and drastically alters patients’ perspective on the future [2]. Patients have to cope with a life limiting illness and many decisions are to be made [3], [4] and [5]. The impact of a bad news consultation is evident and patients often report strong emotions, such as anxiety [6] and [7] and depressive feelings [7] and [8]. However, emotional arousal might not be limited to self-reported psychological arousal. There is growing evidence that the body reacts to mental stress as well [9], [10], [11], [12], [13] and [14]. Stress, negative thoughts and emotions, as for example evoked by the diagnosis of incurable cancer, Ergoloid may activate the sympathetic nervous system (SNS) [15], [16], [17] and [18]. As a subsystem of the autonomic nervous system, the SNS controls visceral functions and operates mostly unconsciously. Activation of the SNS leads to the so-called fight-flight response, which increases physiological arousal and prepares the body for action

[18] and [19]. Physiological arousal is an important underlying component in emotional experiences [15] and [16] and is expected to influence memory of provided information [18]. Indeed, patients’ recall of medical information is problematic: on average patients forget about 40 to 80% of the provided information [5], [20], [21], [22] and [23]. Previous research reported that only 49 to 83% of newly diagnosed cancer patients were able to recall provided information about the proposed treatment correctly [21]. In older cancer patients, recall is even worse; only 21.9% of recommendations nurses made in a consultation about chemotherapy were remembered [5]. The emotional arousal, evoked by the bad news, might be responsible for the poor information recall during medical consultations [5].